Xeris Biopharma Holdings, Inc.
XERSNasdaqCIK 1867096HealthcareFiscal year ends Dec 31
Reports and events: 81 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1407:08 ET | 8-K | 8.01 Other events | 0001867096-26-000091 |
| 2026-09-0908:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000077 |
| 2026-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001867096-26-000065 |
| 2026-08-0607:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-26-000063 |
| 2026-07-1716:20 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001867096-26-000055 |
| 2026-06-3016:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000048 |
| 2026-06-1107:16 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001867096-26-000045 |
| 2026-06-0516:14 ET | 8-K | 5.07 Shareholder vote results | 0001867096-26-000034 |
| 2026-05-0716:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001867096-26-000030 |
| 2026-05-0707:15 ET | 8-K | 2.02 Results of operations | 0001867096-26-000027 |
| 2026-04-2317:08 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001867096-26-000021 |
| 2026-04-2116:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001867096-26-000020 |
| 2026-03-0216:25 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001867096-26-000016 |
| 2026-03-0207:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-26-000012 |
| 2026-02-2718:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-26-000010 |
| 2026-01-0807:18 ET | 8-K | 2.02 Results of operations | 0001867096-26-000004 |
| 2025-12-0107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000161 |
| 2025-11-0616:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001867096-25-000159 |
| 2025-11-0607:43 ET | 8-K | 2.02 Results of operations | 0001867096-25-000156 |
| 2025-08-0716:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001867096-25-000136 |
| 2025-08-0708:02 ET | 8-K | 2.02 Results of operations | 0001867096-25-000130 |
| 2025-06-0417:17 ET | 8-K | 5.07 Shareholder vote results | 0001867096-25-000104 |
| 2025-06-0308:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000100 |
| 2025-05-0816:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001867096-25-000089 |
| 2025-05-0807:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000085 |
| 2025-04-2317:01 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001867096-25-000068 |
| 2025-03-2816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000054 |
| 2025-03-0616:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001867096-25-000039 |
| 2025-03-0607:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000034 |
| 2025-02-2408:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-25-000031 |
| 2025-01-1007:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-25-000017 |
| 2024-11-0816:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001867096-24-000187 |
| 2024-11-0807:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000183 |
| 2024-08-0816:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001867096-24-000162 |
| 2024-08-0807:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000157 |
| 2024-08-0216:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001867096-24-000137 |
| 2024-07-0807:14 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001867096-24-000124 |
| 2024-06-0516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001867096-24-000102 |
| 2024-05-0916:19 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001867096-24-000065 |
| 2024-05-0907:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000062 |
| 2024-04-2316:24 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001867096-24-000053 |
| 2024-03-0616:10 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001867096-24-000031 |
| 2024-03-0607:27 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 8.01 Other events | 0001867096-24-000024 |
| 2024-01-0407:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-24-000003 |
| 2023-11-0916:10 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001867096-23-000139 |
| 2023-11-0907:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001867096-23-000136 |
| 2023-10-1607:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001867096-23-000130 |
| 2023-09-2916:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001867096-23-000125 |
| 2023-09-2708:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001867096-23-000121 |
| 2023-08-0816:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001867096-23-000114 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:37 ET. Listed shows no prices and gives no investment advice.